Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Serum Leucine-rich Alpha-2 Glycoprotein Levels and Endoscopic Activity of Possible Ulcerative Colitis or Crohn's Disease Colitis

NCT04535882 is registered in ClinicalTrials.gov with Showa Inan General Hospital as lead sponsor.

NCT NCT04535882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04535882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Serum Leucine-rich Alpha-2 Glycoprotein Levels and Endoscopic Activity of Possible Ulcerative Colitis or Crohn's Disease Colitis
Lead sponsor
Showa Inan General Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
July 31, 2026
Enrollment
673 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lrg levels